Cargando…
Development of pyrazoline-based derivatives as aminopeptidase N inhibitors to overcome cancer invasion and metastasis
Aminopeptidase N is considered as a promising anti-tumor target due to its role in tumor invasion, metastasis and angiogenesis. In this report, a new series of pyrazoline-based derivatives were designed, synthesized and evaluated for biological activities. The structure–activity relationships of the...
Autores principales: | Cao, Jiangying, Zhao, Chunlong, Dong, Hang, Xu, Qifu, Zhang, Yingjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034162/ https://www.ncbi.nlm.nih.gov/pubmed/35478833 http://dx.doi.org/10.1039/d1ra03629g |
Ejemplares similares
-
Development of Hydroxamate Derivatives Containing a Pyrazoline Moiety as APN Inhibitors to Overcome Angiogenesis
por: Liu, Yangyang, et al.
Publicado: (2022) -
Aminopeptidase N Inhibitors as Pointers for Overcoming Antitumor Treatment Resistance
por: Farsa, Oldřich, et al.
Publicado: (2022) -
Design, Synthesis and Biological Evaluation of Novel Osimertinib-Based HDAC and EGFR Dual Inhibitors
por: Dong, Hang, et al.
Publicado: (2019) -
Aminopeptidase N inhibitors and SARS
por: Kontoyiannis, Dimitrios P, et al.
Publicado: (2003) -
Synthesis and bioevaluation of thienopyrimidines bearing a pyrazoline unit as selective PI3Kα inhibitors
por: Lai, Luogen, et al.
Publicado: (2019)